Abbreviation used in this paper: SAH = subarachnoid hemorrhage.
This article contains some figures that are displayed in color on line but in black-and-white in the print edition.
have a thin adventitia and absent external elastic lamina, and as such are exquisitely sensitive to mechanical trauma. 22 Increased vessel manipulation has been shown to lead to perivascular infarcts and temporary arterial spasm that can be reversed with vasodilation. 13, 19 In addition, it is well known that risk of vasospasm is directly correlated with the volume of SAH surrounding the cerebral vasculature, as breakdown products of erythrocytes and clot lysis are potent activators of vasospasm. 5, 14 Because surgeries with intraoperative rerupture involve additional vessel trauma through manipulation and brief exposure to acute blood while the rerupture is being addressed, it is possible that these patients may be at additional risk of secondary cerebral injury through increased vasospasm.
Identifying an increased rate of vasospasm among patients with intraoperative rerupture would have important clinical implications, as it would justify early aggressive measures to prevent delayed cerebral ischemia through blood pressure augmentation, intravascular volume expansion, and possibly endovascular therapies. The purpose of this study was to evaluate whether intraoperative rerupture of cerebral aneurysms in SAH leads to higher rates of subsequent vasospasm. Such a finding would suggest that this form of secondary brain injury plays a role in the worsened outcomes of these patients.
Methods

Study Design
This study was approved by the Institutional Review Board of the University of California, San Francisco, and was conducted in compliance with Health Insurance Portability and Accountability Act regulations. The study sample was collected by reviewing the University of California, San Francisco, Vascular Neurosurgery database for all surgical ruptured aneurysm treatments performed between January 2006 and June 2012. Patient characteristics, including incidence of intraoperative rerupture, were collected from this prospectively maintained database and verified by chart review. Admission noncontrast head CT scans were reviewed and graded according to the modified Fisher grade by 1 author in a blinded fashion (S.A.S.).
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Inclusion criteria were age > 18, SAH secondary to aneurysmal rupture, and open surgical treatment of ruptured aneurysm. Patients were excluded if the ruptured aneurysm was associated with other vascular pathology such as arteriovenous malformation (n = 9) or was mycotic (n = 3). Patients were also excluded if insufficient documentation was available (n = 3).
Rerupture Assessment
A rerupture event was defined as any egress of blood from the aneurysm during the surgery, including minor bleeding at the time of clip placement or manipulation of the aneurysm dome. Because of this broad definition of rerupture, we also identified the subset of cases in which rerupture lead to a clinical deterioration, which we defined as a change in neurological examination (including depressed mental status, focal weakness, or sensory loss), imaging evidence of new ischemic stroke, or elevated intracranial pressure necessitating additional surgery.
Intraoperative reruptures were managed by a combination of direct tamponade with a neurosurgical paddle, suction, temporary clip placement, trapping, and permanent clipping of the aneurysm. 16 Management of intraoperative rerupture did not always involve extraventricular drain placement. Neurophysiological monitoring with somatosensory evoked potentials was used in every case and assisted with surgical and anesthetic planning.
Vasospasm Assessment
Patients with SAH at our institution are evaluated daily by a multidisciplinary team of neurosurgeons, vascular and critical care neurologists, and medical critical care physicians. 11 These patients undergo serial angiography to monitor for vasospasm, beginning with an immediate postoperative angiogram to confirm successful aneurysm clipping. Subsequent angiograms are then performed for any clinical examination change such as somnolence or a focal deficit, and to follow any vasospasm-related changes noted on prior studies. In addition, patients are followed with daily transcranial Doppler ultrasound studies for the duration of concern for vasospasm, and changes in velocity concerning for vasospasm may also prompt angiographic evaluation. If there are vessel caliber changes on angiography concerning for vasospasm, patients are treated with intraarterial verapamil, and if a proximal lesion is amenable, with angioplasty. Medical management includes close monitoring in the neuroscience intensive care unit with combination therapy of volume expansion and blood pressure augmentation. 16, 17, 23 Angiographic vasospasm was defined as vessel narrowing determined on catheter angiography by the attending interventional neuroradiologist to be consistent with vasospasm. Any degree of vasospasm (mild, moderate, or severe) was considered evidence of angiographic vasospasm. The presence of vasospasm at any time after onset of SAH qualified. Patients were determined to have symptomatic vasospasm if they had evidence of angiographic vasospasm and also experienced a change in their clinical examination believed to be secondary to their vasospasm that was not explained by other causes. In 10 cases (2% of the total) in which catheter angiography was never performed, determination of angiographic spasm was made by findings on transcranial Doppler ultrasonography.
Statistical Analysis
Statistical analyses were performed with GraphPad Prism (version 5.0a, GraphPad Software) and Matlab R2010a (The Mathworks, Inc.). Univariate comparisons between continuous variables (age, time of treatment, number of angiograms) were made with the Mann-Whitney U-test, and between categorical variables (Fisher grade, modified Fisher grade, Hunt and Hess grade, aneurysm location, hypertension, history of smoking, multiple aneurysm treatments, and placement of an extraventricular drain) with the Fisher's exact test. Variables with a p value < 0.01 in univariate analysis were considered statistically significant. Multivariate analysis was performed using binomial logistic regression.
Sample size was determined prior to data collection during the study design phase by assessment of statistical power. An increase in angiographic or symptomatic spasm rate of at least 18% was considered clinically sig-nificant. The sample size required to attain sufficient statistical power (b = 0.8, a = 0.05, 2-sided test) to detect this difference, with continuity correction and assuming unequal groups with a rerupture rate of 15%, was a total of 494 patients (75 patients with rerupture and 419 without).
Results
Patient Demographics
Five hundred fifteen patients were identified, with 15 excluded for reasons listed above, for a total of 500 patients, 75 of whom had intraoperative rerupture (15%). As summarized in Table 1 , the average age of the cohort was 55 ± 14 years, and 72% of the entire cohort was female. For the cohort as a whole, a history of smoking was found in 34% and hypertension in 45%. Twenty percent of the patients had nonruptured aneurysms treated with surgical clip placement at the same time as their ruptured aneurysm treatment.
Subarachnoid Hemorrhage Characteristics
Hunt and Hess grades upon presentation were similar between the groups of patients who had intraoperative rerupture and the group that did not. [8] [9] [10] There were significantly more patients in the group with intraoperative rerupture who presented with Hunt and Hess Grade I (p < 0.01, Fisher's exact test; Table 1 ). Fisher grades and modified Fisher grades between the groups were similar. The duration from the onset of aneurysmal rupture to surgical clipping was also similar between the 2 groups, with a median value of 2 days. The most common locations for aneurysms that were treated for the entire cohort, including nonruptured aneurysms that were treated at the same time as the ruptured aneurysm, were the anterior communicating artery (32%), middle cerebral artery (27%), and posterior communicating artery (22%). In univariate analysis, surgeries involving clipping of posterior communicating artery aneurysms were more likely to involve rerupture (p < 0.01, Fisher's exact test; Table 1 ). Sixteen percent of patients with intraoperative rerupture died during their admission for SAH, compared with 12% of patients without rerupture (p = 0.26, Fisher's exact test).
Management of Complications
There was no significant difference in rates of extraventricular drain placement between the groups with and without rerupture, although there was a trend toward more frequent extraventricular drain usage in the group without rerupture (50% vs 39%, respectively; p = 0.08). Preoperative placement of an extraventricular drain was more common in the group without rerupture (48% vs 29%, respectively; Fisher's exact test), and postoperative extraventricular drain placement was more common in the group with rerupture (9% vs 2%, respectively; p < 0.01, Fisher's exact test). Both groups underwent a similar number of angiograms postoperatively, with a median value of 2 (p = 0.69, 2-tailed Mann-Whitney U-test). The timing of the angiograms was similar, with the first angiogram obtained on hospital Day 2, the second on hospital Day 5, and third (if performed) on hospital Day 8.
Discharge Location
Discharge locations of patients were similar, with 45% of patients in each group discharged home. Rates of discharge to a skilled nursing facility, rehabilitation hospital, or acute hospital transfer were similar between the two groups (44% without vs 39% with rerupture; p = 0.53, Fisher's exact test), as was the rate of in-hospital deaths (12% without vs 16% with rerupture; p = 0.26, Fisher's exact test).
Rerupture and Vasospasm
Intraoperative rerupture did not influence the frequency of angiographic or symptomatic vasospasm. As shown in Fig. 1 , evidence of vasospasm on angiography was observed in 279 (66%) of the 425 patients without rerupture compared with 49 (65%) of the 75 patients with rerupture (p = 1.0, Fisher's exact test). Symptomatic vasospasm was noted in 154 (36%) of the 425 patients without rerupture, compared with 31 (41%) of the 75 patients with rerupture (p = 0.44, Fisher's exact test). There was no difference in the total number of anterior versus posterior treated aneurysms in the no rerupture and rerupture groups: there were 83 anterior (88%) and 11 posterior treated aneurysms (12%) in the rerupture group, and 359 anterior (87%) and 59 posterior (13%) treated aneurysms in the no rerupture group; p = 0.62, Fisher's exact test.
Clinical Deterioration After Surgery
Of the patients who suffered intraoperative rerupture, 20 (27%) were found to have experienced clinical deterioration after surgery. Of those 20 patients, 12 (60%) died in-house, and 40% were discharged to a skilled nursing facility. Compared with patients without rerupture, patients with clinically significant rerupture were less likely to be discharged home (0% vs. 45%, respectively; p < 0.01, Fisher's exact test) and more likely to suffer in-hospital death (60% vs 12%, respectively; p < 0.01, Fisher's exact test). Analysis of vasospasm rates in this subgroup was limited by small sample size as well as treatment bias because these patients likely had a known poor prognosis and care may have been withdrawn earlier; however, in the group of patients with clinically significant rerupture versus the group without rerupture, no differences in the rates of angiographic (50% vs 65%, respectively; p = 0.16, Fisher's exact test) or symptomatic vasospasm (30% vs 36%, respectively; p = 0.64, Fisher's exact test) were found. Fewer angiograms were performed in the group with clinically significant rerupture (median = 1.5) compared with those without rerupture (median = 2; p < 0.01, Mann-Whitney U-test).
Predictors of Vasospasm
Multivariate analysis demonstrated that higher modified Fisher grade was significantly predictive of vasospasm whereas older age and male sex were protective (Table 2 ). There was no significant influence of history of smoking, hypertension, posterior communicating artery location, presence of an extraventricular drain, Hunt and Hess grade, or length of time from rupture to surgical treatment. 
Discussion
In this cohort of patients with SAH from ruptured cerebral aneurysms treated with open surgical clip placement, no significant difference was observed in the rate of angiographic vasospasm or symptomatic vasospasm in patients with and without intraoperative rerupture. The factor most predictive of developing vasospasm was the modified Fisher grade, which is consistent with prior results. 1, 2, [16] [17] [18] 20, 21 We also found older age to be protective, a finding that has also been found previously. 1, 4, 7, 17 Of note, prior reports have also identified smoking and history of hypertension as risk factors for vasospasm, although these findings were not evident in our cohort. 6, 7, 15, 22 Treatment of cerebral vasospasm with volume expansion and hypertension can be effective at mitigating delayed cerebral ischemia associated with vasospasm but is not without potential complications, including pulmonary edema and myocardial infarction. 12, 13, 19 Given the risks, these manipulations should only be performed in the appropriate setting. The findings of this study do not support preemptive early treatment with measures to treat vasospasm for patients with intraoperative rerupture.
Larger cohorts have identified increased death or disability at the time of discharge in patients suffering intraoperative rerupture during SAH. 4, 5, 14, 17 Our study suggests that vasospasm does not play a role in the increased morbidity and death following intraoperative rerupture, and suggests other mechanisms such as periprocedural injury as the cause. In our cohort, acute hemorrhage and vessel manipulations associated with rerupture events did not lead to angiographically or clinically relevant vasospasm. Efforts to mitigate the adverse effects of this complication should be directed toward continued improvement in surgical technique in preventing and responding to intraoperative rerupture.
It is worth noting that in our cohort of patients with rerupture, only 27% had a deterioration in their clinical examination or imaging postoperatively. This subset of patients clearly had worsened outcomes. It is possible that prompt response to the rerupture event mitigated the secondary effects that may have otherwise developed in more patients, highlighting the importance of surgical technique. In addition, this relatively low percentage may preclude the ability to generalize our finding to patients with rupture events that lead to significant vascular injury. It also underscores the importance of defining the degree of hemorrhage that defines a rerupture event. Our rate of rerupture in this study of 15%, or 11% per aneurysm, is comparable to other cohorts. 4, 11, 21 However, studies discussing outcomes or other consequences of this complication will be limited by variability in the definition of rerupture.
Treating ruptured aneurysms with endovascular coiling, as opposed to open surgical clip placement, is another potential means of reducing intraprocedural rupture rates. However, the outcomes of endovascularly treated cases that result in intraprocedural rerupture during coil embolization are often devastatingly poor. 2, 4 It is worth noting that vasospasm rates are not decreased in patients treated with coil embolization versus clip placement, suggesting that the vessel irritation caused by direct manipulation may be offset by drainage of the subarachnoid blood during open surgical treatment. 3, 16 Limitations of this study include aspects related to the retrospective design that are required in a study that examines unintended complications. These aspects include treatment bias, as providers are not blinded to rerupture status. In addition, our study represents the experience of a single institution and the work of almost exclusively a single neurosurgeon (M.T.L.). Different centers and surgeons may have varied intraoperative responses to rupture events and alternate postoperative management strategies, which may result in differing outcomes. The relatively small cohort of reruptured aneurysm cases, and in particular, the small cohort of patients with clinical worsening after rerupture, limits analysis of subgroups such as anterior versus posterior aneurysm location, extraventricular drain placement, Hunt and Hess grade, and others.
Conclusions
This study found no significant influence of intraoperative rerupture during open surgical clip placement on the rate of angiographic or symptomatic vasospasm. These results suggest alternate mechanisms, such as periprocedural injury, as the cause of clinical worsening. In patients with intraoperative rerupture during surgical an eu rysm treatment in SAH, these results do not justify early aggressive treatment with blood pressure augmentation and intravascular volume expansion for the purpose of preventing delayed cerebral ischemia.
